Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-101 Phase 2/3 in Dry Eye Disease
NCT02254265Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Sep 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine ophthalmic solution in keratoconjunctivitis sicca (KCS), sponsored by Sun Pharma. Started Sep 2014; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT02254265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254265.